Factor V Leiden in central venous catheter-associated thrombosis

British Journal of Haematology

Volumn 118, Issue 1, 2002, Pages 267-270

  Fijnheer, Rob ^a   Paijmans, Birgit ^a   Verdonck, Leo F ^a   Nieuwenhuis, H Karel ^a   Roest, Mark ^a   Dekker, Adriaan W ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Haematology ^*

Author keywords

Bone marrow transplantation; Central venous catheter; Factor V Leiden; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CENTRAL VENOUS CATHETER; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MUTATION; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; SUBCLAVIAN VEIN; VEIN THROMBOSIS;

BONE MARROW TRANSPLANTATION; CATHETERIZATION, CENTRAL VENOUS; FACTOR V; HETEROZYGOTE; HUMANS; RISK FACTORS; SUBCLAVIAN VEIN; THROMBOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036062347     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03591.x     Document Type: Article

References (18)

1. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
2. Mutation in blood coagulation factor V associated with resistance to activated protein C
3. Prevention of central venous catheter-associated thrombosis using minidose warfarin in patients with haematological malignancies
4. Subclavian venous thrombosis due to indwelling catheters: A prospective study on 52 patients
5. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation
6. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
7. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation
8. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
9. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
10. No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC) -associated thrombosis in bone marrow transplant recipients
11. Proportion of disease caused or prevented by a given exposure, trait or intervention
12. Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation
13. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications
14. Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women
15. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
16. Thromboembolic complications with silicone elastomer subclavian catheters
17. Resistance to activated protein C as a basis for venous thrombosis
18. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V